Anti-RNA Polymerase III Antibodies in Systemic Sclerosis


Anti-RNA Polymerase III has been recognized as an important autoantibody in Systemic Sclerosis and it is now included in the 2013 ACR/EULAR classification criteria for Systemic Sclerosis. With this manuscript we attempt to review the current data on anti-RNA polymerase II as it relates to Systemic Sclerosis.

Share and Cite:

Kelly, A. and Derk, C. (2015) Anti-RNA Polymerase III Antibodies in Systemic Sclerosis. Open Journal of Rheumatology and Autoimmune Diseases, 5, 81-86. doi: 10.4236/ojra.2015.53013.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Mayes, M.D., Lacey Jr., J.V., Beebe-Dimmer, J., Gillespie, B.W., Cooper, B., Laing, T.J. and Schottenfeld, D. (2003) Prevalence, Incidence, Survival, and Disease Characteristics of Systemic Sclerosis in a Large Us Population. Arthritis & Rheumatism, 48, 2246-2255.
[2] Nihtyanova, S.I., Parker, J.C., Black, C.M., Bunn, C.C. and Denton, C.P. (2009) A Longitudinal Study of Anti-RNA Polymerase III Antibody Levels in Systemic Sclerosis. Rheumatology, 48, 1218-1221.
[3] Arnett, F.C., Cho, M., Chatterjee, S., Aguilar, M.B., Reveille, J.D. and Mayes, M.D. (2001) Familial Occurrence Frequencies and Relative Risks for Systemic Clerosis (Scleroderma) in Three United States Cohorts. Arthritis & Rheumatism, 44, 1359-1362.<1359::AID-ART228>3.0.CO;2-S
[4] Garabrant, D.H., Lacey Jr., J.V., Laing, T.J., Gillespie, B.W., Mayes, M.D., Cooper, B.C. and Schottenfeld, D. (2003) Scleroderma and Solvent Exposure among Women. American Journal of Epidemiology, 157, 493-500.
[5] Reveille, J.D. and Solomon, D.H. (2003) American College of Rheumatology Ad-Hoc Committee of Immunologic Testing Guidelines. Evidence-Based Guidelines for the Use of Immunologic Tests: Anticentromere, Scl-70, and Nucleolar Antibodies. Arthritis & Rheumatism, 49, 399-412.
[6] Aggarwal, R., Lucas, M., Fertig, N., Oddis, C.V. and Medsger Jr., T.A. (2009) Anti-U3 RNP Autoantibodies in Systemic Sclerosis. Arthritis & Rheumatism, 60, 1112-1118.
[7] Oddis, C.V., Okano, Y., Rudert, W.A., Trucco, M., Duquesnoy, R.J. and Medsger Jr., T.A. (1992) Serum Autoantibody to the Nucleolar Antigen PM-Scl. Clinical and Immunogenetic Associations. Arthritis & Rheumatism, 35, 1211- 1217.
[8] Pakozdi, A., Nihtyanova, S., Moinzadeh, P., Ong, V.H., Black, C.M. and Denton, C.P. (2011) Clinical and Serological Hallmarks of Systemic Sclerosis Overlap Syndromes. Journal of Rheumatology, 38, 2406-2409.
[9] van den Hoogen, F., Khanna, D., Fransen, J., Johnson, S.R., Baron, M., et al. (2013) Classification Criteria for Systemic Sclerosis: An American Collge of Rheumatology/European League against Rheumatism Collaborative Initiative. Arthritis & Rheumatism, 65, 2737-2747.
[10] Koenig, M., Dieudé, M. and Senécal, J.L. (2008) Predictive Value of Antinuclear Autoantibodies: The Lessons of the Systemics Clerosis Autoantibodies. Autoimmunity Reviews, 7, 588-593.
[11] Maes, L., Blockmans, D., Verschueren, P., Westhovens, R., De Beéck, K.O., Vermeersch, P., Van den Bergh, K., Burlingame, R.W., Mahler, M. and Bossuyt, X. (2010) Anti-PM/Scl-100 and Anti-RNA-Polymerase III Antibodies in Scleroderma. Clinica Chimica Acta, 411, 965-971.
[12] Satoh, T., Ishikawa, O., Ihn, H., Endo, H., Kawaguchi, Y., Sasaki, T., Goto, D., Takahashi, K., Takahashi, H., Misaki, Y., Mimori, T., Muro, Y., Yazawa, N., Sato, S., Takehara, K. and Kuwana, M. (2009) Clinical Usefulness of Anti- RNA Polymerase III Antibody Measurement by Enzyme-Linked Immunosorbent Assay. Rheumatology, 48, 1570-1574.
[13] Moinzadeh, P., Fonseca, C., Hellmich, M., Shah, A.A., Chighizola, C., Denton, C.P. and Ong, V.H. (2014) Association of Anti-RNA Polymerase III Autoantibodies and Cancer in Scleroderma. Arthritis Research & Therapy, 16, R53.
[14] Okano, Y., Steen, V.D. and Medsger Jr., T.A. (1992) Serum Autoantibodies Reactive with RNA Polymerase III (RP3), A Major Autoantigen in Systemic Sclerosis with Diffuse Cutaneous Involvement. Arthritis & Rheumatism, 35, S3.
[15] Kuwana, M., Kaburaki, J., Mimori, T., Tojo, T. and Homma, M. (1993) Autoantibody Reactive with Three Classes of RNA Polymerases in Sera from Patients with Systemic Sclerosis. Journal of Clinical Investigation, 91, 1399-1404.
[16] Okano, Y., Steen, V.D. and Medsger Jr., T.A. (1993) Autoantibody Reactive with RNA Polymerase III in Systemic Sclerosis. Annals of Internal Medicine, 119, 1005-1013.
[17] Hirakata, M., Okano, Y., Pati, U., Suwa, A., Medsger Jr., T.A., Hardin, J.A. and Craft, J. (1993) Identification of Autoantibodies to RNA Polymerase II. Occurrence in Systemic Sclerosis and Association with Autoantibodies to RNA Polymerases I and III. Journal of Clinical Investigation, 91, 2665-2672.
[18] Yamasaki, Y., Honkanen-Scott, M., Hernandez, L., Ikeda, K., Barker, T., Bubb, M.R., Narain, S., Richards, H.B., Chan, E.K., Reeves, W.H. and Satoh, M. (2006) Nucleolar Staining Cannot Be Used as a Screening Test for the Scleroderma Marker Anti-RNA Polymerase I/III Antibodies. Arthritis & Rheumatism, 54, 3051-3056.
[19] Kuwana, M., Okano, Y., Kaburaki, J., Medsger Jr., T.A. and Wright, T.M. (1999) Autoantibodies to RNA Polymerases Recognize Multiple Subunits and Demonstrate Cross-Reactivity with RNA Polymerase Complexes. Arthritis & Rheumatism, 42, 275-284.<275::AID-ANR9>3.0.CO;2-P
[20] Wang, Z. and Roeder, R.G. (1997) Three Human RNA Polymerase III-Specific Subunits from a Subcomplex with a Selective Function in Specific Transcription Initiation. Genes & Development, 11, 1315-1326.
[21] Kuwana, M., Kimura, K. and Kawakami, Y. (2002) Identification of an Immunodominant Epitope on RNA Polymerase III Recognized by Systemic Sclerosis Sera: Application to Enzyme-Linked Immunosorbent Assay. Arthritis & Rheumatism, 46, 2742-2747.
[22] Sepehri, S. and Hernandez, N. (1997) The Largest Subunit of Human RNA Polymerase III Is Closely Related to the Largest Subunit of Yeast and Trypanosome RNA Polymerase III. Genome Research, 7, 1006-1019.
[23] Bonifazi, M., Tramacere, I., Pomponio, G., Gabrielli, B., Avvedimento, E.V., La Vecchia, C., Negri, E. and Gabrielli, A. (2013) Systemic Sclerosis (Scleroderma) and Cancer Risk: Systematic Review and Meta-Analysis of Observational Studies. Rheumatology, 52, 143-154.
[24] Wooten, M. (2008) Systemic Sclerosis and Malignancy: A Review of the Literature. Southern Medical Journal, 101, 59-62.
[25] Airoò, P., Ceribelli, A., Cavazzana, I., Taraborelli, M., Zingarelli, S. and Franceschini, F. (2011) Malignancies in Italian Patients with Systemic Sclerosis Positive for Anti-RNA Polymerase III Antibodies. The Journal of Rheumatology, 38, 1329-1334.
[26] Shah, A.A., Rosen, A., Hummers, L., Wigley, F. and Casciola-Rosen, L. (2010) Close Temporal Relationship between Onset of Cancer and Scleroderma in Patients with RNA Polymerase I/III Antibodies. Arthritis & Rheumatism, 62, 2787-2795.
[27] Yang, Y., Fujita, J., Tokuda, M., Bandoh, S. and Ishida, T. (2001) Lung Cancer Associated with Several Connective Tissue Diseases: With a Review of Literature. Rheumatology International, 21, 106-111.
[28] Launay, D., Le Berre, R., Hatron, P.Y., Peyrat, J.-P., Hachulla, E., Devulder, B., et al. (2004) Association between Systemic Sclerosis and Breast Cancer: Eight New Cases and Review of the Literature. Clinical Rheumatology, 23, 516- 522.
[29] Scope, A., Sadetzki, S., Sidi, Y., Barzilai, A., Trau, H., Kaufman, B., Catane, R. and Ehrenfeld, M. (2006) Breast Cancer and Scleroderma. SKINmed: Dermatology for the Clinician, 5, 18-24.
[30] Chen, W., Boöcker, W., Brosius, J. and Tiedge, H. (1997) Expression of Neural BC200 RNA in Human Tumours. The Journal of Pathology, 183, 345-351.<345::AID-PATH930>3.0.CO;2-8
[31] Felton-Edkins, Z.A. and White, R.J. (2002) Multiple Mechanisms Contribute to the Activation of RNA Polymerase III Transcription in Cells Transformed by Papovaviruses. The Journal of Biological Chemistry, 277, 48182-48191.
[32] Larminie, C.G., Sutcliffe, J.E., Tosh, K., Winter, A.G., Felton-Edkins, Z.A. and White, R.J. (1999) Activation of RNA Polymerase III Transcription in Cells Transformed by Simian Virus 40. Molecular and Cellular Biology, 19, 4927- 4934.
[33] White, R.J. (2005) RNA Polymerases I and III, Growth Control and Cancer. Nature Reviews Molecular Cell Biology, 6, 69-78.
[34] Kenneth, N.S., Ramsbottom, B.A., Gomez-Roman, N., Marshall, L., Cole, P.A. and White, R.J. (2007) TRRAP and GCN5 Are Used by c-Myc to Activate RNA Polymerase III Transcription. Proceedings of the National Academy of Sciences of the United States of America, 104, 14917-14922.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.